Human Genome Epidemiology Literature Finder
Records 1 - 19 (of 19 Records) |
Query Trace: Neuroblastoma and Braf[original query] |
---|
BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. The Journal of investigative dermatology 2005 Aug 125 (2): 312-7. Akslen Lars A, Angelini Sabrina, Straume Oddbjørn, Bachmann Ingeborg M, Molven Anders, Hemminki Kari, Kumar Raj |
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma. The Journal of investigative dermatology 2006 1 126 (1): 154-60. Goel Vikas K, Lazar Alexander J F, Warneke Carla L, Redston Mark S, Haluska Frank |
Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Feb 18 (3): 748-57. Shukla Neerav, Ameur Nabahet, Yilmaz Ismail, Nafa Khedoudja, Lau Chyau-Yueh, Marchetti Angela, Borsu Laetitia, Barr Frederic G, Ladanyi Ma |
Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling. Molecular cancer therapeutics 2012 Feb 11 (2): 485-91. Chaft Jamie E, Arcila Maria E, Paik Paul K, Lau Christopher, Riely Gregory J, Pietanza M Catherine, Zakowski Maureen F, Rusch Valerie, Sima Camelia S, Ladanyi Marc, Kris Mark |
NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer 2012 Aug 118 (16): 4014-23. Jakob John A, Bassett Roland L, Ng Chaan S, Curry Jonathan L, Joseph Richard W, Alvarado Gladys C, Rohlfs Michelle L, Richard Jessie, Gershenwald Jeffrey E, Kim Kevin B, Lazar Alexander J, Hwu Patrick, Davies Michael |
Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants. Haematologica 2013 Jun 98 (6): 937-44. Driessen Emma M C, van Roon Eddy H J, Spijkers-Hagelstein Jill A P, Schneider Pauline, de Lorenzo Paola, Valsecchi Maria Grazia, Pieters Rob, Stam Ronald |
Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome. Oncology letters 2014 Jul 8 (1): 47-54. Rutkowski Piotr, Gos Aleksandra, Jurkowska Monika, Switaj Tomasz, Dziewirski Wirginiusz, Zdzienicki Marcin, Ptaszy?ski Konrad, Michej Wanda, Tysarowski Andrzej, Siedlecki Janusz |
Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assay. Chinese journal of cancer 2014 Jul 33 (7): 346-50. Su Jian, Zhang Xu-Chao, An She-Juan, Zhong Wen-Zhao, Huang Ying, Chen Shi-Liang, Yan Hong-Hong, Chen Zhi-Hong, Guo Wei-Bang, Huang Xiao-Sui, Wu Yi-Lo |
Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Cancer 2015 Feb 121 (3): 448-56. Villaruz Liza C, Socinski Mark A, Abberbock Shira, Berry Lynne D, Johnson Bruce E, Kwiatkowski David J, Iafrate A John, Varella-Garcia Marileila, Franklin Wilbur A, Camidge D Ross, Sequist Lecia V, Haura Eric B, Ladanyi Mark, Kurland Brenda F, Kugler Kelly, Minna John D, Bunn Paul A, Kris Mark |
PREDICTIVE VALUE OF SOMATIC MUTATIONS FOR THE DEVELOPMENT OF MALIGNANCY IN THYROID NODULES BY CYTOPATHOLOGY. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016 May . Halászlaki Csaba, Tóbiás Bálint, Balla Bernadett, Kósa János P, Horányi János, Bölöny Eszter, Nagy Zsolt, Speer Gábor, Járay Balázs, Székely Eszter, Istók Roland, Székely Tamás, Putz Zsuzsanna, Dank Magdolna, Lakatos Péter, Takács Istv |
Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival. The Journal of investigative dermatology 2016 Feb . Roh Mi Ryung, Gupta Sameer, Park Kyu-Hyun, Chung Kee Yang, Lauss Martin, Flaherty Keith T, Jönsson Göran, Rha Sun Young, Tsao Hens |
Genetic alterations in lung adenocarcinoma with a micropapillary component. Molecular and clinical oncology 2016 Feb 4 (2): 195-200. Furukawa Masashi, Toyooka Shinichi, Ichimura Kouichi, Yamamoto Hiromasa, Soh Junichi, Hashida Shinsuke, Ouchida Mamoru, Shien Kazuhiko, Asano Hiroaki, Tsukuda Kazunori, Miyoshi Shinichi |
Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer. Cancer 2017 May . Lee Dae-Won, Han Sae-Won, Cha Yongjun, Bae Jeong Mo, Kim Hwang-Phill, Lyu Jaemyun, Han Hyojun, Kim Hyoki, Jang Hoon, Bang Duhee, Huh Iksoo, Park Taesung, Won Jae-Kyung, Jeong Seung-Yong, Park Kyu Joo, Kang Gyeong Hoon, Kim Tae-Y |
Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg. Wiener klinische Wochenschrift 2017 May . Rendl Gundula, Rodrigues Margarida, Schweighofer-Zwink Gregor, Hutter Josef, Hittmair Anton, Zellinger Barbara, Hauser-Kronberger Cornelia, Pirich Christi |
Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma. Journal of thoracic disease 2018 Jan 10 (1): 398-407. Zhao Mengnan, Zhan Cheng, Li Ming, Yang Xiaodong, Yang Xinyu, Zhang Yong, Lin Miao, Xia Yifeng, Feng Mingxiang, Wang Q |
Phosphorylation of p70 Ribosomal Protein S6 Kinase ?-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer. Clinical colorectal cancer 2018 Feb . Wiesweg Marcel, Reis Henning, Köster Tobias, Goetz Moritz, Worm Karl, Herold Thomas, Paul Andreas, Dechêne Alexander, Schumacher Brigitte, Markus Peter, Virchow Isabel, Kostbade Karina, Wolf Nathalie, Zaun Gregor, Metzenmacher Martin, Schmid Kurt W, Schuler Martin, Kasper Stef |
Human Papillomavirus Infection, p16 Expression and Genetic Alterations in Vietnamese Cervical Neuroendocrine Cancer. The Malaysian journal of medical sciences : MJMS 2019 11 26 (5): 151-157. Van Ta To, Nguyen Quang Ngoc, Truong Van-Long, Tran Toan Trung, Nguyen Hung Phi, Vuong Linh Di |
Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy. Frontiers in pharmacology 2020 897. De Mattia Elena, Roncato Rossana, Palazzari Elisa, Toffoli Giuseppe, Cecchin Eri |
Undetectable RAS-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients With RAS-Mutant Metastatic Colorectal Cancer. JCO precision oncology 2020 10 4 . Bouchahda Mohamed, Saffroy Raphael, Karaboué Abdoulaye, Hamelin Jocelyne, Innominato Pasquale, Saliba Faouzi, Lévi Francis, Bosselut Nelly, Lemoine Antoinet |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: